The PT Show - Spotlight on Sigourney Bell PHD
Sigourney Bell is a 2 year PhD candidate at the University of Cambridge; Ms Bell researches a rare paediatric brain tumour and is testing novel compounds to develop new therapies.
Prior to starting her PhD research, Sigourney completed a BSc in Human Physiology with Industrial year with honours at the University of Leeds, achieving a 2.1. During her time at Leeds, she developed an interest in neuroscience after doing a voluntary lab placement. She went on to win the Jennifer Rowles Summer studentship to investigate novel therapies for neurodegenerative disorders affecting the spinal cord.
Currently, little is understood about the specific subtype she studies as most patients with such tumours are incurable. She aims to develop a new chemotherapy drug to treat these children to give them a greater chance of living a full, healthy and happy life.
Sigourney Bell is the co-founder of Black in Cancer, promoting Black excellence in research and medicine and educating the community about early diagnosis and advocacy. Sigourney is a first-generation academic and now well on her way in her PhD from the five-year journey since graduating from university.
Sigourney is a fellow ACRC member and Forbes 30 under 30 honouree.
The PT Show - Spotlight on Sigourney Bell PHD
Sigourney Bell is a 2 year PhD candidate at the University of Cambridge; Ms Bell researches a rare paediatric brain tumour and is testing novel compounds to develop new therapies.
Prior to starting her PhD research, Sigourney completed a BSc in Human Physiology with Industrial year with honours at the University of Leeds, achieving a 2.1. During her time at Leeds, she developed an interest in neuroscience after doing a voluntary lab placement. She went on to win the Jennifer Rowles Summer studentship to investigate novel therapies for neurodegenerative disorders affecting the spinal cord.
Currently, little is understood about the specific subtype she studies as most patients with such tumours are incurable. She aims to develop a new chemotherapy drug to treat these children to give them a greater chance of living a full, healthy and happy life.
Sigourney Bell is the co-founder of Black in Cancer, promoting Black excellence in research and medicine and educating the community about early diagnosis and advocacy. Sigourney is a first-generation academic and now well on her way in her PhD from the five-year journey since graduating from university.
Sigourney is a fellow ACRC member and Forbes 30 under 30 honouree.